Senti Biosciences Inc. (SNTI)
Senti Biosciences Statistics
Share Statistics
Senti Biosciences has 4.83M shares outstanding. The number of shares has increased by -43.21% in one year.
Shares Outstanding | 4.83M |
Shares Change (YoY) | -43.21% |
Shares Change (QoQ) | 466.31% |
Owned by Institutions (%) | 5.54% |
Shares Floating | 3.16M |
Failed to Deliver (FTD) Shares | 115 |
FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 65.09K, so 1.35% of the outstanding shares have been sold short.
Short Interest | 65.09K |
Short % of Shares Out | 1.35% |
Short % of Float | 2.15% |
Short Ratio (days to cover) | 3.27 |
Valuation Ratios
The PE ratio is -0.31 and the forward PE ratio is -2.4. Senti Biosciences's PEG ratio is 0.01.
PE Ratio | -0.31 |
Forward PE | -2.4 |
PS Ratio | 0 |
Forward PS | 4.5 |
PB Ratio | 0.63 |
P/FCF Ratio | -0.39 |
PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Senti Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.31.
Current Ratio | 4.49 |
Quick Ratio | 4.49 |
Debt / Equity | 1.31 |
Debt / EBITDA | -0.55 |
Debt / FCF | -0.81 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.55M |
Employee Count | 34 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 4.99% in the last 52 weeks. The beta is 2.53, so Senti Biosciences's price volatility has been higher than the market average.
Beta | 2.53 |
52-Week Price Change | 4.99% |
50-Day Moving Average | 3.81 |
200-Day Moving Average | 3.2 |
Relative Strength Index (RSI) | 50.01 |
Average Volume (20 Days) | 48.5K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -61.04M |
Net Income | -52.79M |
EBITDA | -61.04M |
EBIT | n/a |
Earnings Per Share (EPS) | -11.49 |
Balance Sheet
The company has 48.28M in cash and 33.54M in debt, giving a net cash position of 14.74M.
Cash & Cash Equivalents | 48.28M |
Total Debt | 33.54M |
Net Cash | 14.74M |
Retained Earnings | -297.13M |
Total Assets | 97.84M |
Working Capital | 45.81M |
Cash Flow
In the last 12 months, operating cash flow was -41.4M and capital expenditures -26K, giving a free cash flow of -41.42M.
Operating Cash Flow | -41.4M |
Capital Expenditures | -26K |
Free Cash Flow | -41.42M |
FCF Per Share | -9.01 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SNTI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for SNTI is $12, which is 235.2% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12 |
Price Target Difference | 235.2% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 18, 2024. It was a backward split with a ratio of 1:10.
Last Split Date | Jul 18, 2024 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | -4.43 |
Piotroski F-Score | 3 |